Wells Fargo
GLSI icon

Wells Fargo’s Greenwich LifeSciences GLSI Stock Holding History

Wells Fargo’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$144K Buy
6,144
+3,704
+152% +$90.1K ﹤0.01% 5370
2026
Q1 		$58.6K Sell
2,440
-5,405
-69% -$141K ﹤0.01% 5393
2025
Q4 		$165K Buy
7,845
+4,102
+110% +$43.2K ﹤0.01% 5179
2025
Q3 		$37.2K Buy
3,743
+593
+19% +$6.69K ﹤0.01% 5643
2025
Q2 		$28.6K Buy
3,150
+239
+8% +$2.27K ﹤0.01% 5683
2025
Q1 		$27.8K Buy
2,911
+64
+2% +$776 ﹤0.01% 5602
2024
Q4 		$32K Buy
2,847
+1,008
+55% +$13.5K ﹤0.01% 5623
2024
Q3 		$26.4K Sell
1,839
-72
-4% -$1.07K ﹤0.01% 5560
2024
Q2 		$33K Buy
1,911
+1,870
+4,561% +$27.3K ﹤0.01% 5434
2024
Q1 		$818 Hold
41
– – ﹤0.01% 6190
2023
Q4 		$431 Buy
41
+3
+8% +$30 ﹤0.01% 6418
2023
Q3 		$336 Buy
38
+13
+52% +$122 ﹤0.01% 6448
2023
Q2 		$241 Buy
25
+1
+4% +$11 ﹤0.01% 6647
2023
Q1 		$331 Hold
24
– – ﹤0.01% 6636
2022
Q4 		$365 Buy
24
+1
+4% +$11 ﹤0.01% 6473
2022
Q3 		$0 Sell
23
-4
-15% -$37 ﹤0.01% 6893
2022
Q2 		$0 Sell
27
-894
-97% -$10.2K ﹤0.01% 7043
2022
Q1 		$18K Sell
921
-1,425
-61% -$28.8K ﹤0.01% 6048
2021
Q4 		$57K Buy
2,346
+2,221
+1,777% +$74.3K ﹤0.01% 5908
2021
Q3 		$5K Hold
125
– – ﹤0.01% 6368
2021
Q2 		$6K Sell
125
-1,009
-89% -$38.2K ﹤0.01% 6280
2021
Q1 		$38K Hold
1,134
– – ﹤0.01% 5933
2020
Q4 		$41K Buy
+1,134
New +$16.5K ﹤0.01% 5656

Other funds holding GLSI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Wells Fargo's GLSI Position: Q2 2026 in Review

Wells Fargo increased its Greenwich LifeSciences (GLSI) stake by 152% in Q2 2026, buying an estimated $90.1K and bringing the position to 6,144 shares worth $144K. The position accounts for ﹤0.01% of the portfolio, ranked #5370.

Wells Fargo first reported a position in GLSI in Q4 2020 and has held it in 23 quarters since. The position peaked at $165K in Q4 2025. 57 funds tracked by Wall St. Rank hold GLSI as of Q2 2026.

  • Wells Fargo held 6,144 shares of Greenwich LifeSciences worth $144K as of Q2 2026.
  • Wells Fargo bought 3,704 Greenwich LifeSciences shares in Q2 2026, an estimated $90.1K.
  • Greenwich LifeSciences made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #5370 holding.
  • Wells Fargo first reported a position in Greenwich LifeSciences in Q4 2020 and has held it in 23 quarters since.
  • Wells Fargo's Greenwich LifeSciences position peaked at $165K in Q4 2025.
  • 57 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.